西班牙Certest嗜肺軍團菌單抗(克隆LN14)

廣州健侖生物科技有限公司

廣州健侖長期供應各種生物原料，主要代理品牌：西班牙Certest。

主要產品包括各種生物單克隆抗原抗體、重組蛋白。

西班牙Certest嗜肺軍團菌單抗(克隆LN14)

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

歡迎咨詢

歡迎咨詢2042552662

【產品介紹】

西班牙Certest嗜肺軍團菌單抗(克隆LN14)

目前，研究人員正在進行毒理學、細胞移植、預臨床研究和臨床研究之前的概念驗證等研究。他們表示，研究讓他們朝著利用干細胞移植治療人類疾病又邁近了一步。
人體的另一個謎題已經被科學家解開了，科學家已經確定了一個在人類發育工作中*的分子馬達。他們還正確的指出，與該馬達相關的基因突變為什么會引發各種各樣的人類疾病。
英國布里斯托爾大學的研究人員已經確定了人類版本的分子馬達組成，它被稱為“胞質動力蛋白-2”，這對于正常的人類發育有著至關重要的作用。動力蛋白2指引分子進入纖毛以及控制其沿著纖毛運動。
纖毛是一種細長突起，幾乎充當了所有人體細胞的觸須，它們在傳感信號指導細胞功能中具有很重要的作用。已知，纖毛功能失調會引發長期癱瘓和有時甚至危及生命的遺傳病。這會對多個系統產生影響，導致失明，耳聾，慢性呼吸道感染，腎疾病，心臟疾病，抗原抗體，肥胖和糖尿病。
這些人類疾病統稱為ciliopathies，其中許多這種疾病，包括年輕綜合征(Jeune Syndrome)，都與兒童的發育有關。在英國，每10萬個嬰兒中就有一個在出生時患有年輕綜合征——這是一種罕見的遺傳疾病，會影響孩子的軟骨和骨骼發育。
這項新的研究是由醫學研究委員會資助，并且發表于2014年9月9日的《Journal of Cell science》雜志上，*精確的解釋人類胞質動力蛋白-2馬達是如何工作的。這項新的成果可能有助于診斷，并且科學家希望他們能夠改變缺陷馬達的功能，有益于治療。
來自布里斯托爾大學的生物化學學院的戴維·斯蒂芬斯教授了這項研究。他說：“這個馬達新組分的發現，給我們提供了一個很好地機會，去了解缺乏動力蛋白-2是如何引發疾病的。”
在簡單的模型生物體(如綠藻)上完成工作，研究還表明，與年輕綜合征相關的兩個基因(WDR34和WDR60)是人類版本中這種馬達的必要組成部分。
形成一個功能性動力蛋白-2馬達需要這兩個基因編碼的蛋白質，這就解釋了為什么任一個基因發生突變都會引發ciliopathy。這項工作還確定了動力蛋白-2的新組分(TCTEX1D2)，提供一個候選基因，其突變或可導致年輕綜合征。

西班牙Certest嗜肺軍團菌單抗(克隆LN14)

想了解更多的產品及服務請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室

Currently, researchers are conducting toxicology, cell transplantation, pre-clinical studies and proof-of-concept studies prior to clinical studies. They said the latest research has taken them one step closer to using stem cell transplantation to treat human disease.
Another mystery of the human body has been solved by scientists, who have identified a molecular motor that is indispensable in the work of human development. They also rightly pointed out why genetic mutations associated with the motor can trigger a wide range of human diseases.
Researchers at the University of Bristol in the United Kingdom have identified a human version of the molecular motor composition called "cytoplasmic dynein-2," which plays a crucial role in normal human development. Motokin 2 directs molecules into the cilia and controls their movement along the cilia.
Cilia is an elongated protrusion that acts almost as a whisker of all human cells and plays an important role in sensing signaling functions of cells. It is known that cilia dysfunction can cause long-term paralysis and sometimes life-threatening genetic diseases. This can affect multiple systems, resulting in blindness, deafness, chronic respiratory infections, kidney disease, heart disease, antigen-antibody, obesity and diabetes.
These human diseases are collectively referred to as ciliopathies, and many of these diseases, including the Jeune Syndrome, are related to children's development. In the UK, one out of every 100,000 infants is born with a young syndrome - a rare genetic disorder that affects the child's cartilage and bone development.
This new study, funded by the Medical Research Council and published in the September 9, 2014 issue of the Journal of Cell Sciences, for the first time accuray explains how the human cytoplasmic dynein-2 motor works. The new results may help diagnose, and scientists hope they will be able to change the function of the defective motor, beneficial treatment.
Professor David Stephens from the University of Bristol's School of Biochemistry led the study. "The discovery of new components in this motor provides us with a good opportunity to understand how the lack of dynamin-2 can trigger disease," he said.
Working on a simple model organism, such as green algae, studies have also shown that two genes associated with young syndromes (WDR34 and WDR60) are essential components of this motor in the human version.
The formation of a functional dynein-2 motor requires proteins encoded by both genes, which explains why mutations in either gene can trigger ciliopathy. This work also identified a new component of dynein-2 (TCTEX1D2), which provides a candidate gene whose mutation may lead to young syndrome.